The Japanese Government and universities have started a probe over the research projects involving Hisashi Moriguchi, a researcher at University of Tokyo Hospital, who had falsely claimed to have carried out the world's first clinical trial using the trailblazing stem cell technology.
The Cabinet Office and the science and health ministries, as well as the University of Tokyo, Tokyo Medical and Dental University and Kyorin University plan to investigate what role Moriguchi may have played in the projects and whether his purported achievements are true.
Moriguchi, 48, said last week that he performed treatment using pluripotent stem (iPS) cells, which have the potential to grow into any type of body tissue, on six people but later admitted most of his claim was false, the Japan Times reports.
"While the treatment was implemented, it was only one procedure. At the end of the day, I lied," he said at a news conference Saturday in New York.
The Cabinet Office has asked the Japan Society for the Promotion of Science, which is managing a four-year project aimed at developing refrigeration techniques for cells and body organs that will run through fiscal 2013, to look into Moriguchi's contributions.
Moriguchi was involved in two research projects, which was subsidized by the government between fiscal 2001 and 2005, and received a combined 20.7 million Yen in subsidies, concerning topics such as the comparison of cooperation between business and academia in Japan and the U.S. and did not involve experiments or surgery, the paper said. (ANI)